Direct Selective Laser Trabeculoplasty Providing Effective Intraocular Pressure Reduction in Pigmentary Glaucoma Patients
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate (based on AAO Preferred Practice Program criteria) pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field/RNFL loss.
• Treatment naive, or washed out IOP ranging from ≥18-34 mmHg
• Central corneal thickness (CCT) 480-600 µm
• Able to complete medication washout and follow-up
Locations
United States
Texas
Mann Eye Institute
RECRUITING
Houston
Contact Information
Primary
Melissa Wright
Melissa.Wright@manneye.com
713-580-2500
Time Frame
Start Date: 2026-03-19
Estimated Completion Date: 2027-04-01
Participants
Target number of participants: 45
Related Therapeutic Areas
Sponsors
Leads: Mann Eye Institute
Collaborators: Sengi